Patent foramen ovale and cryptogenic stroke

Free article

Comment

George C Newman. N Engl J Med. 2013.

Free article

. 2013 Jul 4;369(1):90.

doi: 10.1056/NEJMc1305429.

No abstract available

Comment in

Patent foramen ovale and cryptogenic stroke.
Meier B, Jüni P. Meier B, et al. N Engl J Med. 2013 Jul 4;369(1):91. doi: 10.1056/NEJMc1305429. N Engl J Med. 2013. PMID: 23822782 No abstract available.
Patent foramen ovale and cryptogenic stroke.
Carroll JD, Saver JL; Steering Committee of the RESPECT Investigators. Carroll JD, et al. N Engl J Med. 2013 Jul 4;369(1):91-2. doi: 10.1056/NEJMc1305429. N Engl J Med. 2013. PMID: 23833784 No abstract available.
Patent foramen ovale and cryptogenic stroke.
Messé SR, Kent DM. Messé SR, et al. N Engl J Med. 2013 Jul 4;369(1):92-3. doi: 10.1056/NEJMc1305429. N Engl J Med. 2013. PMID: 23833785 No abstract available.

Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators. Meier B, et al. N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716. N Engl J Med. 2013. PMID: 23514285 Clinical Trial.
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Carroll JD, et al. N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440. N Engl J Med. 2013. PMID: 23514286 Clinical Trial.